ACBSP Installs its First Board Chair From Latin America —

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
28
ACBSP Installs its First Board Chair From Latin America — Alejandro Jose Cheyne Garcia, Universidad del Rosario, Bogotá, Colombia

OVERLAND PARK, KS, USA, July 13, 2018 (GLOBE NEWSWIRE) -- Dr. Alejandro Jose Cheyne Garcia, Dean – School of Business, Universidad del Rosario in Bogotá, Colombia, has been elected Chair of the Board of Directors for the Accreditation Council for Business Schools and Programs (ACBSP) www.acbsp.org , the only global accrediting body to accredit business, accounting, and business-related programs at all degree levels. He is the first member affiliated with a university from Latin America to assume the office of Chair. The announcement was made at the ACBSP Annual Conference, held June 8-11 in Kansas City, Missouri. Dr. Cheyne began his one-year term at the conclusion of that conference.

 

Dr. Cheyne has been instrumental in building awareness of ACBSP accreditation among business schools across Latin America for more than a decade. The helped establish the Latin American Council for Business Schools and Programs – ACBSP Region 9 in 2009, and served as the region’s secretary, vice present and president. He led the accreditation teams at two universities with which he was affiliated, the first was Uniempresarial – Fundacion Universitaria Empresarial, with business programs accredited by ACBSP in 2013, and most recently Universidad del Rosario, with business programs accredited by ACBSP in 2017. Dr. Cheyne has also been actively involved at the international level as well, serving on the ACBSP Strategic Planning Committee and serving as mentor and evaluator to many campuses pursuing accreditation through ACBSP.  

 

“Alejandro has a deep passion for his students and for enhancing the quality of business schools in Latin America and throughout the world,” said Jeffrey Alderman, ACBSP President and CEO. “He is a respected leader in Colombia and is quick to share his rich knowledge of leadership and entrepreneurship. I look forward to being part of the audience this year as he brings a unique perspective to his role as Chair of the Board of Directors of this organization.”    

 

“I have had the chance to meet amazing people, who not only supported our accreditation process but who also invited me to participate in ACBSP,” said Dr. Cheyne. “Serving as secretary, vice president, and president of ACBSP Region 9 has allowed me to work with Latin American leaders to face their regional challenges and with ACBSP global leaders who demonstrate how schools can work together around education.” 

 

About Alejandro Jose Cheyne Garcia

Alejandro Cheyne holds a doctorate degree in pedagogy and studies in international management and business administration. He is considered one of the most important professors in higher education programs in Colombia. He is an Economist from Universidad del Rosario and he has developed a career around leadership and entrepreneurship. He is currently President of the Business Process Outsourcing, Knowledge Process Outsourcing and Information Technology Outsourcing Board in Colombia and Chair of the ACBSP Board of Directors.

 

About ACBSP

ACBSP, www.acbsp.org , is a leading specialized accreditation body for business education. ACBSP’s mission is to promote continuous improvement and recognize teaching excellence in the accreditation of business education programs throughout the world. Recognized by the Council for Higher Education Accreditation (CHEA) in 2001 and again in 2011, ACBSP was the first to offer specialized business accreditation at all degree levels. ACBSP currently accredits business programs at nearly 1,200 campuses in 60 countries. FAQs / Accreditation FAQs

 

Video file: http://bit.ly/2z86HuP  

###

Attachment

Melinda Dorning Accreditation Council for Business Schools and Programs (ACBSP) 913-339-9356 mdorning@acbsp.org

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading